Yüklüyor......

How Abbott’s Fenofibrate Franchise Avoided Generic Competition

The ongoing debate concerning the efficacy of fenofibrate has overshadowed an important aspect of the drug’s history: Abbott, the maker of branded fenofibrate, has produced several bioequivalent reformulations, which dominate the market even though generic fenofibrate has been available for almost a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Downing, Nicholas S., Ross, Joseph S., Jackevicius, Cynthia A., Krumholz, Harlan M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3636774/
https://ncbi.nlm.nih.gov/pubmed/22493409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archinternmed.2012.187
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!